Page 91 - Livre électronique des RFTP 2023
P. 91

P53.           CAN        WE       PREDICT           SEVERITY           OF      ACUTE

               EXACERBATION IN INTERSTIAL LUNG DISEASE?

               W. JELASSI1, A. HEDHLI1, N. H. KHEZAMI1, K. EUCHI1, Y. OUAHCHI1, S. TOUJANI1, S.
               CHEIKHROUHOU1, M. MJID1, B. DHAHRI1.

               1TUNIS  EL MANAR UNIVERSITY, FACULTY OF  MEDICINE OF TUNIS,  LA RABTA  HOSPITAL,
               PULMONOLOGYDEPARTMENT, LR18SP02, TUNIS, TUNISIA



               INTRODUCTION : The term acute exacerbation of interstitial lung disease (ILD)
               refers to a deterioration  that  occurs  suddenly and clinically in a way  that  is
               significant  within a  month but has no  apparent medical  explanation. Idiopathic
               pulmonary fibrosis (IPF) acute exacerbations have been the subject of numerous
               investigations, but less is known about similar occurrences in other ILDs that could
               have a progressive-fibrosing pattern.

               The aim of this study is to determine predicting factors of acute exacerbation of
               interstitial lung disease (AE-ILD).

               METHODS  :  A descriptive study  was  conducted on 64 patients followed for
               confirmed ILD in our pulmonology department in La Rabta teaching hospital from
               January 2018 until April 2023. Sociodemographic information, clinical, spirometric
               and radiological features as well as blood test results were collected from medical
               records.

               RESULTS : Our population consisted of 35 (54,7%) men and 29 (45,3%) women. The
               mean age was 67,70 +- 11,27 years. The distribution of ILD sub types was as follows:
               33 (51,6%) patients had Idiopathic pulmonary fibrosis (IPF), 10 (15,6%) patients had
               connective tissue-associated ILD (CTD-ILD),  7 (10%) patients  had non-specific
               interstitial lung disease, 12 (18,8%) had pulmonary sarcoidosis and 1 (1,6%) patient
               had chronic hypersensitivity pneumonitis (CHP).

               The median length of follow up was 30,22 months (IQR: 4,22 - 56,2 months ). Thirty-
               three (51,6%) patients had AE-ILD, 39 (60%) patients had a significant decline in CVF
               of more than 10% and 18 (28,1%) patients died. The desaturation in the 6-minute
               walk test, the development  of fibrosis,  and the chronic  respiratory  failure  were
               strongly correlated with frequent AE-ILD (r=0,565, p=0,04; r=,334, p=0,01 and r=0,56,
               p<10-3 respectively). Fibrosis and Declin in FVC of more than 10% were correlated
               with the risk of hospitalisation for AE-ILD due to acute respiratory failure (r=0,37,
               p=0,001 and r= ,377, p=0,001). IPF was the sub type that was the most associated
               with death due to AE-ILD (p=0,01).

               CONCLUSION  :  Acute exacerbations of interstitial  lung  disease are  a serious
               condition with a high rate of in-hospital mortality. The clinical course seems to be
               more fatal in IPF compared to non-IPF ILD.






                                                                                              89 | Pa g e
   86   87   88   89   90   91   92   93   94   95   96